Keybank National Association Exelixis, Inc. Transaction History

Keybank National Association

$25.5 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$16.3 - $19.41 $94,898 - $113,005	-5,822 Reduced 26.19%	16,404 $318,000
Q4 2022 Jan 31, 2023	SELL	$14.96 - $17.39 $8,467 - $9,842	-566 Reduced 2.48%	22,226 $356,000
Q3 2022 Oct 27, 2022	SELL	$15.68 - $22.27 $36,910 - $52,423	-2,354 Reduced 9.36%	22,792 $357,000
Q1 2022 Apr 28, 2022	SELL	$17.03 - $22.67 $295,879 - $393,868	-17,374 Reduced 40.86%	25,146 $570,000
Q4 2021 Feb 07, 2022	BUY	$15.84 - $21.88 $25,391 - $35,073	1,603 Added 3.92%	42,520 $777,000
Q3 2021 Nov 08, 2021	BUY	$16.3 - $21.14 $40,750 - $52,850	2,500 Added 6.51%	40,917 $865,000
Q2 2021 Aug 12, 2021	BUY	$17.95 - $25.56 $293,985 - $418,621	16,378 Added 74.31%	38,417 $700,000
Q1 2021 May 07, 2021	SELL	$20.53 - $25.22 $457,757 - $562,330	-22,297 Reduced 50.29%	22,039 $498,000
Q4 2020 Feb 09, 2021	BUY	$18.39 - $24.8 $214,445 - $289,192	11,661 Added 35.69%	44,336 $890,000
Q3 2020 Oct 29, 2020	BUY	$20.67 - $26.94 $411,849 - $536,779	19,925 Added 156.27%	32,675 $799,000
Q1 2020 May 13, 2020	SELL	$14.46 - $21.8 $50,826 - $76,627	-3,515 Reduced 21.61%	12,750 $220,000
Q4 2019 Feb 05, 2020	BUY	$15.15 - $18.89 $53,252 - $66,398	3,515 Added 27.57%	16,265 $287,000
Q2 2019 Aug 01, 2019	SELL	$18.93 - $24.75 $4,732 - $6,187	-250 Reduced 1.92%	12,750 $272,000
Q1 2019 May 08, 2019	BUY	$19.6 - $24.76 $19,600 - $24,760	1,000 Added 8.33%	13,000 $309,000
Q4 2018 Jan 30, 2019	SELL	$13.65 - $21.8 $68,250 - $109,000	-5,000 Reduced 29.41%	12,000 $236,000
Q3 2018 Nov 08, 2018	SELL	$15.87 - $22.4 $3,174 - $4,480	-200 Reduced 1.16%	17,000 $301,000
Q2 2018 Aug 08, 2018	SELL	$18.56 - $22.45 $428,550 - $518,370	-23,090 Reduced 57.31%	17,200 $370,000
Q1 2018 May 15, 2018	SELL	$22.15 - $31.89 $99,741 - $143,600	-4,503 Reduced 10.05%	40,290 $892,000
Q4 2017 Feb 08, 2018	BUY	$24.23 - $30.93 $578,927 - $739,010	23,893 Added 114.32%	44,793 $1.36 Million
Q2 2017 May 14, 2018	SELL	N/A	-100 Reduced 0.48%	20,900 $515,000
Q4 2016 May 14, 2018	BUY	N/A	21,000	21,000 $313,000

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.2 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.05 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$913 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$552 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$411 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Account